M. Guidi

Discipline

Psychologie (2) Anthropologie biologique (1)

Discipline

Littératures (1) Linguistique (1)

Type de document

Articles (28) Colloques et conférences (3) Recensions (2)

Type de document

Autres (1) Billets de blog (1) Articles (1)

Co-auteur

Auteur

Date

Date

Source

Source

Mot-clé

pharmacocinétique (21) Pharmacokinetics (21) Pharmacokinetics (21) modèle (20) Example (20) Population (20) Population (19) dosage (18) Treatment (18) exposition (16) dose (14) Patients (14) Patients (14) Models (14) Drug monitoring (12) Therapeutics (12) Modeling (12) Human beings (12) plasma (12) thérapie (11) abords (agglomération) (11) Absorption (11) cohorte (11) âge (10) Elimination (10) Drugs (10) Age (10) Age (10) Area (9) Area (9)

Mot-clé

Grenoble (1) Oscillations (1) Oriental antiquities (1) French (1) Bâtiment universitaire (1) Français (1) Oscillations (1) Antiquités orientales (1) français (langue) (1) Français (1) Princeton (1) Grenoble (1) Compiègne (1) Bruxelles (1)

Documents écrit par M. Guidi (31) | parle de M. Guidi (2)

Évaluation des risques liés aux médicaments pendant l’allaitement [Risk assessment of drugs during breastfeeding]
E. Cardoso et al. (18 oct. 2023)
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.
F. Gaspar et al.
Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-study.
P. Thoueille et al. (27 sept. 2023)
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
C. Bandiera et al. (3 janv. 2023)
Precision oncology by point-of-care therapeutic drug monitoring and dosage adjustment of conventional cytotoxic chemotherapies: A perspective.
M. Briki et al. (2023)
From personalized to precision medicine in oncology: A model-based dosing approach to optimize achievement of imatinib target exposure.
S. Goutelle et al. (2023)
Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children.
S. Goutelle et al. (1 oct. 2022)
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation.
M. Guidi et al.
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
P. Thoueille et al. (29 juil. 2022)
Model-based meta-analysis of salbutamol pharmacokinetics and practical implications for doping control.
P. Courlet et al.
Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation.
K. Dao et al. (2 févr. 2022)
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs.
P. Courlet et al.
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.
I.H. Bartelink et al. (2021)
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV.
P. Courlet et al.
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma.
D. Balakirouchenane et al. (9 avr. 2020)
Optimisation of vancomycin exposure in neonates based on the best level of evidence.
K. Dao et al.
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses.
A. Glatard et al.
Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers.
K. Dao et al.
The steps to therapeutic drug monitoring: A structured approach illustrated with imatinib
T. Buclin et al. (2020)
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy.
C. Barceló et al.
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV.
P. Courlet et al.
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population.
A. Glatard et al.
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
M. Guidi et al. (18 avr. 2019)
Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial.
O. Sottas et al. (2019)
Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients.
M. Guidi et al.

next
Oscillations, Вistability and Waves in Вiochemical and Cellular Systems
ldiebold (2 juin 1997)
Du nouveau sur Ibn Ḳuzmān
Évariste Lévi-provençal (1947)